Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection

NCT05218070 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: EgyVax Vaccine Candidate
DRUG: Placebo

Sponsor

Eva Pharma

Collaborators

[object Object]
[object Object]
[object Object]